Related Experiment Video
Updated: Sep 9, 2025

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Inhibition of protein kinase R suppresses HIV replication and integration in CD4 T cells
Jaeden Pyburn1,2, Juan Zhao1,2, Ling Wang1,2
1Center of Excellence for Inflammation, Infectious Disease and Immunity, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, 37614, USA.
In early HIV infection, researchers found that inhibiting protein kinase R (PKR) in CD4 T cells suppressed HIV replication. This suggests PKR is a potential therapeutic target for treating HIV.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- CD4 T cell status is crucial for managing early HIV infection and controlling viral replication.
- Understanding cellular mechanisms of survival in HIV-infected cells is key to developing effective therapies.
Purpose of the Study:
- To investigate cell survival mechanisms in HIV-infected CD4 T cells during early infection.
- To explore the role of phosphorylated eukaryotic translation initiation factor 2-alpha (p-eIF2α) and protein kinase R (PKR) in HIV replication.
Main Methods:
- Infection of CD4 T cells with HIV-1.
- Quantification of p-eIF2α levels in infected versus uninfected cells.
- Inhibition of PKR in HIV-infected cells to assess its impact on viral markers.
Main Results:
- HIV-infected CD4 T cells showed increased levels of p-eIF2α compared to uninfected cells.
- PKR inhibition in infected cells significantly reduced HIV p24 protein expression.
- PKR inhibition disrupted HIV reverse transcription and integration processes.
Conclusions:
- Elevated p-eIF2α is a characteristic of early HIV infection in CD4 T cells.
- Targeting PKR presents a promising therapeutic strategy to combat HIV infection by inhibiting viral replication.
More Related Videos
09:26In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 15, 2013
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
Related Concept Videos
Retrovirus Life Cycles
Inhibition of Cdk Activity
Size and Structure of Viral Genomes